Clinical Trials, Phase III as Topic
Clinical Trials, Phase 3 as Topic
Drug Evaluation, FDA Phase 3 as Topic
Drug Evaluation, FDA Phase III as Topic
Evaluation Studies, FDA Phase 3 as Topic
Evaluation Studies, FDA Phase III as Topic
Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.